Clinical Trial Update: Glenzocimab for REperfusion in the Setting of Endovascular Therapy for Brain infarctioN: GREEN Study [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial update for glenzocimab in reperfusion during endovascular therapy for acute ischemic stroke, with study currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke Acute
• Stroke Ischemic

Drugs mentioned

• Glenzocimab (Glenzocimab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Stroke, Acute, Stroke, Ischemic | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING